Prosight Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Prosight Management's PFE Position: Q3 2026 in Review
Prosight Management sold out of Pfizer (PFE) in Q3 2026, closing a stake of 135,366 shares — an estimated $3.26M sold.
Prosight Management first reported a position in PFE in Q1 2024 and held it in 2 quarters. The position peaked at $5.97M in Q1 2024. 2,908 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Prosight Management reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- Prosight Management sold 135,366 Pfizer shares in Q3 2026, an estimated $3.26M.
- Prosight Management first reported a position in Pfizer in Q1 2024 and held it in 2 quarters.
- Prosight Management's Pfizer position peaked at $5.97M in Q1 2024.
- 2,908 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Prosight Management's 13F filing for Q3 2026, filed 13 Nov 2026.